Rx Medicare

Genome Institute of Singapore scientists, led by Christopher Wong, Ph.D., have developed a novel approach to uncover the complete sequence of any influenza A virus, including H1NI, with just a quick nasal swab or nasal pharyngeal wash from patients.

Read More…

Related Posts

• PositiveID Corporation Successfully Completes Phase I Development Of Its Rapid Virus Detection System
• NanoViricides Platform Enables Rapid Development Of Robust Nanomedicines Against Influenza And HIV
• Warnex Launches Test For Influenza A H1N1 Virus Mutation Associated With Resistance To Tamiflu(R)
• Drug Resistant Influenza A Virus Potentially Serious To High-Risk Patients
• Study Documents Increasing Prevalence Of Influenza A Resistance To Drug Oseltamivir
• Atomic Resolution Details Of A Promising Drug Target In Influenza Virus
• Diagnostic Hybrids Receives FDA Emergency Use Authorization For D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
• WHO Investigates Cases Of H1N1 Drug Resistance In U.S., Britain
• FDA Approves Additional Vaccine For 2009 H1N1 Influenza Virus
• NanoViricides, Inc. To Present Anti-Influenza Drug Candidate FluCide™ Studies At The Influenza Congress 2009
• Paradigm Shift Needed To Combat Drug Resistance
• Meridian Granted Special 510(k) Clearance To Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim To The TRU FLU(R) Test Package Insert
• Diagnostic HYBRIDS Gets FDA Clearance For The Detection Of Influenza A (H1N1)v Virus
• Flu Virus Ill-Suited For Rapid Transmission, But Researchers Say New Strain Bears Watching, Could Mutate
• Cases Of The 2009 H1N1 Influenza A Virus Confirmed In Crawford And Miami Counties

Tags: approach, development, drug, efficacy, identify, influenza, mutations, rapid, resistance, virus

This entry was posted on Monday, June 1st, 2009 at 8:06 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.